Table 3. Clinical therapeutic efficacy, M-TXYF vs. RP.
| Study | Effective rate, % (efficacy/N) | Therapeutic gain, % | NNT | OR (95% CI) | |
|---|---|---|---|---|---|
| M-TXYF | Positive medicine | ||||
| An et al. 2017 (10) | 96.9 (31/32) | 75.0 (24/32) | 21.9 | 4.6 | 10.33 (1.21, 88.36) |
| Chen et al. 2016 (11) | 93.3 (28/30) | 70.0 (21/30) | 23.3 | 4.3 | 6.00 (1.17, 30.72) |
| Ge et al. 2016 (12) | 93.5 (58/62) | 71.0 (44/62) | 22.5 | 4.4 | 5.93 (1.87, 18.77) |
| Ma et al. 2016 (13) | 91.3 (21/23) | 69.6 (16/23) | 21.7 | 4.6 | 4.59 (0.84, 25.16) |
| Qian et al. 2016 (14) | 96.7 (29/30) | 76.7 (23/30) | 20.0 | 5.0 | 8.83 (1.01, 76.96) |
| Li et al. 2015 (15) | 90.0 (27/30) | 73.3 (22/30) | 16.7 | 6.0 | 3.27 (0.77, 13.83) |
| Li 2015 (16) | 90.5 (38/42) | 71.4 (30/42) | 19.1 | 5.2 | 3.80 (1.11, 12.98) |
| Peng et al. 2014 (17) | 88.9 (24/27) | 65.2 (15/23) | 23.7 | 4.2 | 4.27 (0.98, 18.66) |
| Wen et al. 2014 (18) | 92.9 (39/42) | 73.8 (31/42) | 19.1 | 5.2 | 4.61 (1.18, 17.99) |
| Chen et al. 2014 (19) | 82.8 (48/58) | 77.6 (35/58) | 5.2 | 19.2 | 3.15 (1.33, 7.46) |
| Zhang et al. 2014 (20) | 90.7 (39/43) | 69.0 (29/42) | 21.7 | 4.6 | 5.98 (1.56, 22.90) |
| Tu 2013 (21) | 96.4 (54/56) | 93.8 (45/48) | 2.6 | 38.5 | 1.80 (0.29, 11.25) |
| Wang et al. 2013 (22) | 89.5 (43/48) | 76.0 (38/50) | 13.5 | 7.4 | 2.72 (0.88, 8.41) |
| Wang et al. 2012 (23) | 93.3 (42/45) | 75.6 (34/45) | 17.7 | 5.6 | 4.53 (1.17, 17.55) |
| Tao et al. 2012 (24) | 94.1 (64/68) | 79.7 (51/64) | 14.4 | 6.9 | 4.08 (1.25, 13.27) |
| Xu et al. 2011 (25) | 98.1 (51/52) | 79.0 (41/52) | 19.1 | 5.2 | 13.68 (1.70, 110.40) |
| Zhang 2010 (26) | 93.0 (37/40) | 63.0 (25/40) | 30.0 | 3.3 | 7.40 (1.94, 28.24) |
| Zhang et al. 2009 (27) | 90.6 (48/53) | 70.4 (38/54) | 20.2 | 5.0 | 4.04 (1.36, 12.03) |
| Liang et al. 2009 (28) | 85.0 (17/20) | 45.0 (9/20) | 40.0 | 2.5 | 6.93 (1.53, 31.38) |
| Pan et al. 2009 (29) | 90.9 (70/77) | 92.5 (37/40) | -1.6 | -62.5 | 0.81 (0.20, 3.32) |
| Gao et al. 2009 (30) | 71.6 (53/74) | 40.9 (9/22) | 30.7 | 3.3 | 3.65 (1.36, 9.80) |
| Fang 2008 (31) | 90.0 (36/40) | 70.0 (28/40) | 20.0 | 5.0 | 3.86 (1.12, 13.26) |
| Cai et al. 2006 (32) | 86.7 (52/60) | 77.4 (24/31) | 9.3 | 10.8 | 1.90 (0.62, 5.83) |
| Pooled OR | 90.3 (950/1052) | 72.7 (669/920) | 17.6 | 5.7 | 4.04 (3.09, 5.27) |
NNT, number needed to treat; OR, odds ratio.